JP2004513885A5 - - Google Patents

Download PDF

Info

Publication number
JP2004513885A5
JP2004513885A5 JP2002523486A JP2002523486A JP2004513885A5 JP 2004513885 A5 JP2004513885 A5 JP 2004513885A5 JP 2002523486 A JP2002523486 A JP 2002523486A JP 2002523486 A JP2002523486 A JP 2002523486A JP 2004513885 A5 JP2004513885 A5 JP 2004513885A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
kit
compound
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002523486A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004513885A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/026792 external-priority patent/WO2002018368A1/en
Publication of JP2004513885A publication Critical patent/JP2004513885A/ja
Publication of JP2004513885A5 publication Critical patent/JP2004513885A5/ja
Pending legal-status Critical Current

Links

JP2002523486A 2000-08-30 2001-08-28 ファルネシルタンパク質トランスフェラーゼインヒビターである三環式抗腫瘍化合物 Pending JP2004513885A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22918300P 2000-08-30 2000-08-30
PCT/US2001/026792 WO2002018368A1 (en) 2000-08-30 2001-08-28 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors

Publications (2)

Publication Number Publication Date
JP2004513885A JP2004513885A (ja) 2004-05-13
JP2004513885A5 true JP2004513885A5 (enExample) 2008-09-25

Family

ID=22860141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002523486A Pending JP2004513885A (ja) 2000-08-30 2001-08-28 ファルネシルタンパク質トランスフェラーゼインヒビターである三環式抗腫瘍化合物

Country Status (27)

Country Link
US (1) US20020198216A1 (enExample)
EP (1) EP1313725B1 (enExample)
JP (1) JP2004513885A (enExample)
KR (1) KR20030034161A (enExample)
CN (1) CN100384837C (enExample)
AR (1) AR033680A1 (enExample)
AT (1) ATE359281T1 (enExample)
AU (2) AU8845101A (enExample)
BR (1) BR0113675A (enExample)
CA (1) CA2420673A1 (enExample)
CO (1) CO5640109A2 (enExample)
DE (1) DE60127846T2 (enExample)
EC (1) ECSP034494A (enExample)
ES (1) ES2284686T3 (enExample)
HK (1) HK1054548B (enExample)
HU (1) HUP0302942A3 (enExample)
IL (1) IL154528A0 (enExample)
MX (1) MXPA03001849A (enExample)
NO (1) NO20030918L (enExample)
NZ (1) NZ524246A (enExample)
PE (1) PE20020486A1 (enExample)
PL (1) PL361103A1 (enExample)
RU (1) RU2293734C9 (enExample)
SK (1) SK2292003A3 (enExample)
TW (1) TWI268280B (enExample)
WO (1) WO2002018368A1 (enExample)
ZA (1) ZA200301545B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
EE05417B1 (et) * 2001-03-14 2011-06-15 Bristol-Myers Squibb Company Epotilooni analoogide ja kemoterapeutikumide kombinatsiooni kasutamine teraapias
JP2005531488A (ja) * 2001-10-09 2005-10-20 ザ・ユニバーシティ・オブ・シンシナティ 甲状腺癌を処置するためのegf受容体阻害剤
EP1448268A2 (en) * 2001-11-30 2004-08-25 Schering Corporation Use of an farnesyl protein transferase inhibitor in combination with other antineoplastic agents for the manufacture of a medicament against cancer
JP2005515201A (ja) * 2001-12-03 2005-05-26 シェーリング コーポレイション 癌の処置におけるfptインヒビターおよび少なくとも2つの抗腫瘍性剤の使用
US20030195192A1 (en) * 2002-04-05 2003-10-16 Fortuna Haviv Nicotinamides having antiangiogenic activity
US20040014744A1 (en) * 2002-04-05 2004-01-22 Fortuna Haviv Substituted pyridines having antiangiogenic activity
EP1606285A4 (en) * 2003-03-27 2009-03-18 Lankenau Inst Medical Res NEW IDO HEMMER AND APPLICATION PROCEDURES
EP1628631A2 (en) * 2003-06-05 2006-03-01 Achkar, Charles C. Methods of treating hyperproliferative cell disorders
BRPI0411250A (pt) * 2003-06-09 2006-08-29 Samuel Waksal método de inibição de receptor tirosina cinase com um antagonista extracelular e um antagonista intracellular
ES2235611B2 (es) * 2003-07-25 2006-07-16 Universidade De Santiago De Compostela Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas.
BRPI0413384A (pt) * 2003-08-07 2006-10-17 Schering Corp inibidores da proteìna farnesil transferase como agentes antitumores
US7592466B2 (en) 2003-10-09 2009-09-22 Abbott Laboratories Ureas having antiangiogenic activity
MY138124A (en) * 2004-12-21 2009-04-30 Schering Corp Novel farnesyl protein transferase inhibitors as antitumor agents
RU2361587C1 (ru) * 2008-02-14 2009-07-20 Михаил Владимирович Кутушов Лекарственное средство для лечения онкологических заболеваний
CA2730190A1 (en) * 2008-07-14 2010-01-21 Queen's University At Kingston Pharmaceutical compositions comprising ret inhibitors and methods for the treatment of cancer
WO2020258211A1 (en) * 2019-06-28 2020-12-30 Anhui Ronghang Biotech Development Co., Ltd. Compositions and methods for treatment of hepatitis b virus infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IL98572A (en) * 1990-06-22 1995-07-31 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene, piperidylidene and piperazine compositions an methods of use
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
PE92098A1 (es) * 1996-07-31 1998-12-31 Schering Corp N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
US6071907A (en) * 1996-09-13 2000-06-06 Schering Corporation Tricyclic compounds useful as FPT inhibitors
US5925648A (en) * 1997-07-29 1999-07-20 Schering Corporation Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase
CA2354774C (en) * 1998-12-18 2009-05-26 Schering Corporation Farnesyl protein transferase inhibitors

Similar Documents

Publication Publication Date Title
JP2004513885A5 (enExample)
CN101641117B (zh) 药物组合物
RU2008117295A (ru) Новые пиразолопиримидины как ингибиторы циклинзависимых киназ
RU2008122967A (ru) Имидазопиразины в качестве ингибиторов протеинкиназ
RU2003108865A (ru) Трициклические противоопухолевые соединения, являющиеся ингибиторами фарнезилпротеинтрансферазы
RU2008150419A (ru) ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ CDK
WO2015138902A1 (en) Combination therapy with glutaminase inhibitors
MXPA05003119A (es) Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas.
RU2006132288A (ru) Производные пиразолопиримидина, как ингибиторы циклин-зависимой киназы
CA2497544A1 (en) Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors
CN110730664A (zh) 含谷氨酰胺酶抑制剂的组合疗法
CA2499756A1 (en) Imidazopyrazines as cyclin dependent kinase inhibitors
AU2018294351A1 (en) Compositions and methods for modulating hair growth
WO2016014890A1 (en) Treatment of multiple myeloma with heterocyclic inhibitors of glutaminase
JP2004510733A5 (enExample)
IS5588A (is) Æxliseyðandi miðlar
US20080214509A1 (en) Methods for enhancing the efficacy of vascular disrupting agents
AU756762B2 (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
JP2001526224A5 (enExample)
JP2024160336A (ja) トリス構造を有するリンカーを含むリガンド―薬物複合体
CA2191850C (en) Cancerous metastasis inhibitor
CA3240724A1 (en) Combination of antibody-drug conjugate and atr inhibitor
JP2021521219A (ja) Bet阻害剤およびプロテアソーム阻害剤を用いる併用療法
KR102501394B1 (ko) 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체
TW201306833A (zh) 包含康布列塔司他汀(combretastatins)族衍生物及西妥昔單抗(cetuximab)之組合